AbbVie

0
Emails

AbbVie is a global biopharmaceutical company specializing in research and development of advanced therapies for complex diseases such as immunology, oncology, and neuroscience.

Tracking

Track Brand

Frequently Sends

Thursday

Common Send Time

6-8 AM

Links Per Email Avg

18

Links

Images Per Email Avg

7

Images

Sender Addresses

4 Emails Used

Website

abbvie.com

Get Brand Highlights

Understand their sending frequency, number of links, sender address and more.

View PlansUpgrade

AbbVie

Visit Website
0
Emails
AbbVie Press Release: AbbVie Acquires Celsius Therapeutics
June 27, 2024
Business and Collaboration Outreach
AbbVie Press Release: U.S. Food and Drug Administration Grants Second Approval for EPKINLY® (epcoritamab-bysp) to Treat Patients with Relapsed or Refractory Follicular Lymphoma
June 26, 2024
Product Announcements
AbbVie Press Release: AbbVie Provides U.S. Regulatory Update on ABBV-951 (Foscarbidopa/Foslevodopa)
June 25, 2024
Product Announcements

Upgrade to track a brand

To track a brand and get insights you must upgrade.

Compare PlansUpgrade
DiscoverBlogSponsorshipContact UsFAQTerms & Conditions
Join Free
© 2024 Email Emu. All rights reserved.
© Email Emu 2024
Feedback
Provide Feedback On
Description
Thank you for your feedback!
Damn. Something went wrong Please try again.